Oliver STRAWBRIDGE
Total number of appointments 25
SHIRE BIOPHARMACEUTICALS HOLDINGS (05492592)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
THE ENDOCRINE CENTRE LIMITED (02603613)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
LUMENA PHARMA UK LIMITED (08456823)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 30 September 2015
- Resigned on
- 1 March 2018
SHIRE PHARMACEUTICALS SERVICES LIMITED (04420273)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE HUMAN GENETIC THERAPIES LIMITED (04243270)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE HOLDINGS UK LIMITED (04666500)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE US INVESTMENTS (06275900)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE GLOBAL FINANCE (05418960)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 21 March 2016
- Resigned on
- 1 March 2018
SPARKLEFLAME LIMITED (03114531)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE EUROPE FINANCE (05193881)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
MONMOUTH PHARMACEUTICALS LIMITED (01809476)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE HUMAN GENETIC THERAPIES UK LIMITED (04061406)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE PHARMACEUTICALS LIMITED (02031674)
- Company status
- Active
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE HOLDINGS EUROPE LIMITED (03158354)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
NPS PHARMA UK LIMITED (05996334)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
RYBAR LABORATORIES LIMITED (00366644)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
AURALIS LIMITED (05335695)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE UK INVESTMENTS LIMITED (05542355)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595)
- Company status
- Active
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE EUROPE LIMITED (06561859)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE PHARMACEUTICALS GROUP (02883758)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE HOLDINGS UK CANADA LIMITED (05965409)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
VIROPHARMA LIMITED (06246349)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED (02486738)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018
SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY (04343659)
- Company status
- Dissolved
- Correspondence address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Role Resigned
- Secretary
- Appointed on
- 18 November 2015
- Resigned on
- 1 March 2018